| Term 
 
        | Major Depression clinical features
 |  | Definition 
 
        | Depressed mood, loss of pleasure or interest in all or nearly all of one's usual activities and past times. Characterized by insomnia/hypersomnia, anorexia/hyperphasgia, mental slow/loss of concentration, guilt, worthlessness, helplessness, death/sucidal thoughts, suicidal behaviors. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | s/s present most of day, nearly every day >2wks |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | -complex & incomplete understanding -can be 'out of blue'
 -stressful events
 -factors that contribute to vulnerability:genetic, difficult childhood, chronic low self-esteem
 -monamine deficiency hypothesis-defiecient in serotonin, NE or both
 |  | 
        |  | 
        
        | Term 
 
        | Major depression tx modalities
 |  | Definition 
 
        | Pharmacotherapy Depression specific psychotherapy
 Somatic therapy (ECT, transcranial magnetic stimulation, light therapy, vagus nerve stimulation)
 Aerobic exercise& resistance training
 |  | 
        |  | 
        
        | Term 
 
        | Major Depression Atypical features
 |  | Definition 
 
        | reactive mood, significant increase in appetite, wt gain, hypersomnia, heavy feelings in arms/legs, sensitive to interpersonal rejection |  | 
        |  | 
        
        | Term 
 
        | Major presentation Assessment
 |  | Definition 
 
        | H&P:include medications (?side effect) MMSE, Lab work (r/o electrolytes/hypothyroid other medical conditions)
 Differential dx
 |  | 
        |  | 
        
        | Term 
 
        | Medical disorders associated w/Depression |  | Definition 
 
        | Endocrine disorders, deficiency states, infections, collagen disorders, metabolic disorders, CV disease, neurologic disorder, malignant disease |  | 
        |  | 
        
        | Term 
 
        | Psychiatric disorders associated w/depression |  | Definition 
 
        | alcoholism, anxiety, eating disorders, schizophrenia |  | 
        |  | 
        
        | Term 
 
        | Drug therapies associated w/depression |  | Definition 
 
        | Anti-hypertensives, hormonal therapy, acne therapy, other |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Major depressive disorder Dysthymic disorder
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Chronic depressed mood most days >2yrs, combined with 2 of the following: appetite or sleep disturbance, low energy, low self-esteem, hoplesness, poor concentration, indecisiveness. |  | 
        |  | 
        
        | Term 
 
        | Depression symptom pneumonic |  | Definition 
 
        | SIG E CAPS sleep, interest, guilt, energy, concentration, appetite, psychomotor, suicide
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | reduce/resolve problems prevent relapse
 facilitate to baseline
 prevent suicide
 improve QOL
 normalize functionabl relationships
 avoid/minimize adverse effect
 reduce health care costs
 |  | 
        |  | 
        
        | Term 
 
        | Drug classes for depression |  | Definition 
 
        | SSRI SNRI
 TCA
 MAOI
 mixed serotonin
 mixed NE/DA reuptake inhibitors
 |  | 
        |  | 
        
        | Term 
 
        | Basic time course for antidepresants |  | Definition 
 
        | 1-3 wks to start working, max responses 12wks |  | 
        |  | 
        
        | Term 
 
        | Drug selection for antidepressants |  | Definition 
 
        | Tolerability, safety, interactions, pt preferance, cost. Can try a different one with in same class
 |  | 
        |  | 
        
        | Term 
 
        | Antidepressant choice for pt c/o fatigue |  | Definition 
 
        | drug w/CNS stimulation Prozac, Wellbutrin
 |  | 
        |  | 
        
        | Term 
 
        | Antidepressant choice for pt c/o insomnia
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antidepressant choice for pt c/o sexual dysfunction, low libido
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Antidepressant choice for pt c/o Chronic pain
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | Managing treatment in depression |  | Definition 
 
        | Once started use 4-8 weeks before determining efficacy. Start low dose. Options if not effective:increase dose, switch within same class, switch to a different class, add a second drug. Once in remission-cont 4-9mths symptom free, taper off.
 |  | 
        |  | 
        
        | Term 
 
        | Suicide risk with antidepressants |  | Definition 
 
        | Increased when starting antidepressants and when dose increases. Evaluate weekly x4wks, biweekly x4wks, x1 month, periodic
 |  | 
        |  | 
        
        | Term 
 
        | Treatment phases with antidepressants |  | Definition 
 
        | Acute, continuation, maintenance |  | 
        |  | 
        
        | Term 
 
        | Antidepressants Duration of treatment phases
 |  | Definition 
 
        | Acute-6weeks Continuation-6-9mths
 Maintenance-3-5yrs, lifelong
 |  | 
        |  | 
        
        | Term 
 
        | Antidepressants Goals of treatment phases
 |  | Definition 
 
        | Acute-resolve symptoms Continuation-prevent relapse
 Maintenance-prevent reoccurance in high risk pts
 |  | 
        |  | 
        
        | Term 
 
        | High risk patients for lifelong maintenance of depression |  | Definition 
 
        | *first episode >50y/o *>40y/o who have had 2+ episodes
 *all ages with 3+ episodes
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Prozac, Zoloft, Celexa, Lexapro,Paxil, Luvox |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Block neuronal reuptake of serotonin increasing serotonin at synapses |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | high protein bound, extensive hepatic metabolism CYP2D6, 1/2 life 2 days, 4wks to plateau |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sexual dysfunction, nausea, HA, CNS stimulation, nervous, insomnia, anxiety, wt. gain, serotonin syndrome, withdrawl symptoms with abrupt dc(less than others),increase suicide risk, EPS (akthisia most common), bruxism, hyponatremia, dizzy, fatigue, skin rash, diarrhea, excessive sweating. Teratogenic. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOIs(stop 14 days before start,wait 5wksafter prozac to start MAOI) CYP2D6 drugs, TCAs, Lithium, antiplatelet & anticoags, tagament, ethanol, NSAIDs, TCAs, some antiHTN, warfarin, tryptophan, other serotonergic meds
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Na at baseline & periodic in elderly |  | 
        |  | 
        
        | Term 
 
        | Prozac minimizing side effects
 |  | Definition 
 
        | Manage sexual dysfunction-drug holidays (off on weekends), add yohimbine, Buspar, Wellbutrin, remeron, Viagra.Bruixism-switch class or use mouthgaurds and add Buspar |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | absorption increase with food, high protein binding, extensive hepatic metabolism. 1/2 life 1 day.(side effects same as prozac) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | same as prozac + dry mouth, constipation, sedative (rather than excitatory), liver damage. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Liver function baseline & weekly x1month |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Same as prozac, but fatigue/somnolence that fades after 5-6 wks. Has some anticholinergic effects. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Celexa-paresthesias, dry mouth, tachycardia, orthostatic hypotension, QT prolongation (and all other of prozac) |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | 2-72hrs after tx onset. Altered mental status (agitated, confused, disoriented, anxiety, hallucinations, poor concentration_, incoordination, myoclonus, hyperreflexia, excessive sweating, tremor, fever, death |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dizzy, HA, nausea, sensory disturbances, tremor, anxiety, dysphoria, days-weeks after stopping & last 1-3 weeks. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Effexor, Pristiq, Cymbalta |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Block NE, serotonin, and DA reuptake. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Nausea, HA, anorexia, nervous, sweating, somnolence, insomnia. Dose dependent wt loss, sustained DBP HTN, sexual dysfunction, mydriasis, hyponatremia, serotonin syndrome, teratogenic |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOIs within last 14 days of 7 days after withdrawl syndrome. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOIs, Tagament, St. Johns Wart, Triptans, other antidepressants |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Dizzy, diarrhea/contispation, dry mouth, erectile dysfunction, decrease libido, seizures (and all of Effexor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | take on empty stomach. high protein bound. CYP2D6, CYP1A2 metabolism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | decreased appetite, blurred vision, liver damage (and all of pristiq/effexor) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Transaminases (ALT), eye exams for glaucoma |  | 
        |  | 
        
        | Term 
 
        | Cymbalta contraindications
 |  | Definition 
 
        | narrow-angle glaucoma, liver dysfunction, alcoholics, Cr Cl <30 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Alcohol, MAOIs, CYP1A2 & CYP2D6 drugs, phenothiazines, other antidepressants, drugs that increase serotonin syndrome risk |  | 
        |  | 
        
        | Term 
 
        | Tricylic Antidepressants drug list
 |  | Definition 
 
        | Amitriptyline, clomipramine,desipramine, doxepin, imipramine, nortrptyline, protriptyline, trimipramine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Block reuptake, of serotonin and norepinepherine. Block histamine and ACh. Potency varies between drugs. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | ANTICHOLINERGIC (except diaphoresis), ORTHOSTATIC HYPOTENSION, SEDATION,cardiac conduction delays, weight gain, excessive sweating, sexual dysfunction, seizure, hypomania, suicide risk |  | 
        |  | 
        
        | Term 
 
        | TCA choice by pretx symptoms insomnia
 sedation
 BPH, glaucoma
 Contraindicated in urinary retention & glaucoma, seizure
 highest cardiotoxic risk
 |  | Definition 
 
        | insomnia-give doxepin sedation-give desipramine
 BPH,glaucoma-give nortriptyline
 contra glaucoma/urine retention-doxepin
 contra seizure-maprotiline
 cardiotoxic-desipramine
 |  | 
        |  | 
        
        | Term 
 
        | Anafril additional side effect
 |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | slow rise/change position, caution in operating machinery/driving, sugar free candy for dry mouth, do not take 2 doses if miss one |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | BP/P, orthostatics, EKG prior to tx and periodic. Some drugs have serum levels |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | used for suicide attempts-do not give suicidal pts more than one week supply. Dysrhthmias, hyperthermia, flush, dry mouth, dilated pupils, early-confusion, agitation, hallucinations.Later seizure & coma |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | gastric lavage, physostigmine, propranolol, lidocaine, phenytoin |  | 
        |  | 
        
        | Term 
 
        | Anticholinergic pneumonic |  | Definition 
 
        | BUDCAT Blurry vision, photophobia, ^IOP
 Urinary retention
 Dry mouth/reduced secretions
 Constipation
 Anhidrosis (absence of sweat)
 Tachycardia
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Class IA antiarrhythmics tagament
 QT prolongers
 Several CYP 450 meds
 MAOIs (can under close supervison)
 direct & indirect sympathmoimetics
 anticholinergics
 CNS depressants
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selegiline patch, Marplan, Nardil, Parnate |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAO, an enzyme in liver, intestine & some neuron terminals. MAO neurons convert NE, serotonin,& DA to inactive. In liver & intestines, inactivates tyramine
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | All MAOIs for depression are nonselective (effect neuron, liver, intestine). Antidepressant effect are from increasing NE and serotonin available for release. Can be reversible or irreversible. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 1st line in atypical depression 2-3rd in other depression, bullimia, OCD, panic attacks
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CNS stimulation (anxiety, insomnia, agitation, hypomania, mania), orthostatic hypotension, hypotension, dizzy, lightheaded, anticholinergic, (?sedation), sexual dysfunction, HTN crisis with dietary tyramine, hepatocellular damage, wt. gain, edema |  | 
        |  | 
        
        | Term 
 
        | HTN crisis with tyramine foods s/s
 |  | Definition 
 
        | severe HA, tachycardia,palpitations, HTN, N/V, confusion, profuse sweating, stroke |  | 
        |  | 
        
        | Term 
 
        | Normal tyramine food metabolism |  | Definition 
 
        | MAO in intestine and liver inactivate before reaching general circulation |  | 
        |  | 
        
        | Term 
 
        | Tyramine effects in general circulation |  | Definition 
 
        | Stimulates release of accumulated NE, massive vasocontriction and intense heart stimulation |  | 
        |  | 
        
        | Term 
 
        | Foods with tyramine and tyramine-like foods to avoid
 |  | Definition 
 
        | yeast, cheese, avacodos, soybeans, salami, pepperoni, bologna, smoked meats, figs, bananas, aged fish/meat, liver, beer, Chianti Wine, protein dietary supplements, soups, shrimp paste, soy sauce, caffeine,chocolate, fava, ginseng |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | IV vasodilator, sodium nitroprusside, phentolamine, labetalol, sl nifedipine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | A LOT, lots of OTC also. Pt teaching to notify prescriber before starting any new med-including OTC (ie cough/cold) |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | 24h MAOI patch, no dietary restrict for 6mg, avoid in  anesthetic comtaining sympathomimetics. Contraindicated in pheochromocytoma. May increase q2weeks |  | 
        |  | 
        
        | Term 
 
        | Changing therapies from/to MAOI |  | Definition 
 
        | wait 2 week from stopping MAOIs to start other antidepressants and vice versa. Wait 5 wks after Prozac to start MAOI. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | similar structure to amphetamine. Stimulant actions & supresses appetite. Antidepressant effects 1-3 weeks. Sexual dysfunction in SSRI pts and women w/hypoactive libido, SAD, major depressive, smoking cessation, neuropathy, ADHD
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | r/t block dopamine &/or NE reuptake |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | CYP2B6 hepatic metabolism, 1/2 life 8-24h |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | seizures, agitation, HA, dry mouth, constipation, wt. loss, GI upset, dizzy, tremor, insomnia, blurred vision, tachycardia, psychotic, suicide risk |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Zoloft, prozac, paxil, MAOI, CYP2B6 |  | 
        |  | 
        
        | Term 
 
        | Bupropion minimizing seizure risk
 |  | Definition 
 
        | avoid dose >450mg/day, avoid rapid titration(<100/day >3-4days inbetween), avoid single dose >150mgavoid use in hx of seizures, head injury, CNS tumor, or with drugs that decrease seizure threshold |  | 
        |  | 
        
        | Term 
 
        | Bupropion Contraindications
 |  | Definition 
 
        | eating disorders, previous seizure hx. |  | 
        |  | 
        
        | Term 
 | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | Inhibits NE and serotonin reuptake |  | 
        |  | 
        
        | Term 
 
        | Trazadone/nefazadone side effects
 |  | Definition 
 
        | HA, drowsy, insomnia, agitation, dizzy, dry mouth, nausea, constipation, weakness, trazadone-priapism/prolonged clitoral erection & QT prolongation |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Sleep adjunct in depression
 |  | 
        |  | 
        
        | Term 
 
        | Nefazone uses/additional considerations
 |  | Definition 
 
        | Antidepressant Assoc w/Liver failure
 Protein bound
 |  | 
        |  | 
        
        | Term 
 
        | Trazadone/nefazadone interactions
 |  | Definition 
 
        | 3A4 drugs, digoxin, MAOIs, warfarin, CNS depressants, St. Johns wort |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | inhibits NE & serotonin reuptake by inhibiting receptors, avoids some serotonin receptors, block histamine |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | sedation, increased cholesterol, constipation, dry mouth, increased appetite, wt. gain, dizzy |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | daily HS, adjust for hepatic and renal impair |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOIs, clonidine, triptans, BZD, other antidepressants, CNS depressants |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Selective block serotonin reuptake and direct activation of serotonin receptors |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | Take w/food, high protein bound, extensive hepatic metabolism |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | diarrhea, nausea, dizzy, insomnia, sexual dysfunction,serotonin syndrome, hyponatremia, abnormal bleeding, increased suicide |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | MAOIs, serotonergic drugs, CYP drugs, anticoags & antiplatelets |  | 
        |  | 
        
        | Term 
 
        | Amoxapine use/side effects
 |  | Definition 
 
        | Antidepressant for psychotic depression. anticholinergic, sedative, seizure, EPS, TD
 |  | 
        |  | 
        
        | Term 
 
        | Ketamine as an antidepressant
 |  | Definition 
 
        | IV-quickly reduces depression and suicide, 40minute results last 10days side effect-psychosis resolves in 40min, can cause cancer
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        | SSRI use, pheochomocytoma, HF, liver disease, severe renal impair, cerbrovascular disease, HTN, >60y/o |  | 
        |  | 
        
        | Term 
 
        | ADVERSE EFFECTS Remeron
 Neazodone
 Trazodone
 Bupropion
 MAOIs
 Antidepressants
 |  | Definition 
 
        | Neutropenia/agrulocytosis(avoid immunosuppressed) Hepatic Failure
 Priapism
 Seizures
 HTN crisis
 Suicidality
 |  | 
        |  |